Какова цена за Energenesis Biomedical CO.,LTD. (6657)

Цена за Energenesis Biomedical CO.,LTD. (6657) Это $0.97305026

Какова рыночная капитализация для Energenesis Biomedical CO.,LTD. (6657)

Рыночная капитализация для Energenesis Biomedical CO.,LTD. (6657) Это $85.54M

Energenesis Biomedical CO.,LTD. (6657) Дивиденды

Energenesis Biomedical CO.,LTD., a firm established in 2012 and headquartered in Taipei, Taiwan, is an active participant in the biomedicine sector. The company specializes in the development of a diverse range of medical solutions and research materials. Its primary pharmaceutical pipeline includes ENERGI-F703, which is currently undergoing Phase II clinical trials for the treatment of diabetic foot ulcers, and ENERGI-F701, a topical solution for addressing alopecia that is also in its second phase of clinical assessment. The comprehensive portfolio of therapeutic agents further encompasses: ENERGI-F711, formulated as a cream for burns. ENERGI-F702, designed to combat metabolic diseases. ENERGI-F704, targeting inflammatory bowel disease. ENERGI-F708, for the management of asthma. ENERGI-F705, aimed at controlling Parkinson's disease. ENERGI-F707, addressing mitochondrial deficiencies. ENERGI-F706, used to treat cachexia. ENERGI-F709, which serves as a vaccine adjuvant. ENERGI-F710, intended for the regulation of blood phosphate levels. Beyond its therapeutic developments, Energenesis Biomedical also provides a selection of scientific research products, including reagents for Western blotting, cell culture supplements, components for protein isolation and quantification, various laboratory dyes, and buffer solutions.

Год	Дивиденды (с учетом дробления акций)	Изменить
Недостаточно данных для указанных дат.

Год

Дивиденды (с учетом дробления акций)

Изменить

Недостаточно данных для указанных дат.

Год	Дивиденд	Изменить
Недостаточно данных для указанных дат.

Год

Дивиденд

Изменить

Недостаточно данных для указанных дат.

Компания	Количество дивидендных выплат	Страна
Vertex Pharmaceuticals Incorporated VRTX.US	0.00%	US
Argenx SE ARGX.US	0.00%	NL
Moderna, Inc. MRNA.US	0.00%	US
CSL Limited CSL.AX	64.00%	AU
Lonza Group AG LONN.SW	0.00%	CH

Компания

Количество дивидендных выплат

Страна